These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Epstein-Barr-virus immunity and tissue distribution in a fatal case of infectious mononucleosis. Britton S, Andersson-Anvret M, Gergely P, Henle W, Jondal M, Klein G, Sandstedt B, Svedmyr E. N Engl J Med; 1978 Jan 12; 298(2):89-92. PubMed ID: 201839 [No Abstract] [Full Text] [Related]
3. Epstein-Barr virus infections. Middleton PJ. Can Med Assoc J; 1974 Jan 05; 110(1):9-10. PubMed ID: 4358535 [No Abstract] [Full Text] [Related]
4. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells. Wasik M, Myc A, Matej H, Rudzka L. Arch Immunol Ther Exp (Warsz); 1983 Jan 05; 31(6):871-8. PubMed ID: 6331340 [Abstract] [Full Text] [Related]
5. Epstein-barr-virus nuclear antigen. Vonka V, Hirsch I. Prog Med Virol; 1982 Jan 05; 28():145-79. PubMed ID: 6283600 [No Abstract] [Full Text] [Related]
15. Virus-specified proteins and their breakdown products. In: strategy of the viral genome. Ciba Found Symp; 1971 Jan 05; ():295-315. PubMed ID: 4337205 [No Abstract] [Full Text] [Related]
16. Letter: Epstein-Barr viral antibodies and leukocyte-transforming agent in infectious mononucleosis. Chang RS, Cooper TY, Simpson EE. N Engl J Med; 1976 Jun 17; 294(25):1404-5. PubMed ID: 177877 [No Abstract] [Full Text] [Related]
17. [Significance of the Epstein-Barr virus and cytomegalovirus antibody demonstration in the diagnosis of infectious mononucleosis]. Schmitz H. Verh Dtsch Ges Inn Med; 1972 Jun 17; 78():930-3. PubMed ID: 4353157 [No Abstract] [Full Text] [Related]